1. Benzyl derivatives with in vitro binding affinity for human opioid and cannabinoid receptors from the fungus Eurotium repens.
- Author
-
Gao J, León F, Radwan MM, Dale OR, Husni AS, Manly SP, Lupien S, Wang X, Hill RA, Dugan FM, Cutler HG, and Cutler SJ
- Subjects
- Alkaloids chemistry, Animals, Benzene Derivatives chemistry, Benzofurans chemistry, Cricetinae, Cricetulus, Georgia, Humans, Molecular Structure, Stereoisomerism, Alkaloids isolation & purification, Alkaloids pharmacology, Benzene Derivatives isolation & purification, Benzene Derivatives pharmacology, Benzofurans isolation & purification, Benzofurans pharmacology, Eurotium chemistry, Receptors, Cannabinoid drug effects, Receptors, Opioid drug effects
- Abstract
Bioassay-guided fractionation of the fungus Eurotium repens resulted in the isolation of two new benzyl derivatives, (E)-2-(hept-1-enyl)-3-(hydroxymethyl)-5-(3-methylbut-2-enyl)benzene-1,4-diol (1) and (E)-4-(hept-1-enyl)-7-(3-methylbut-2-enyl)-2,3-dihydrobenzofuran-2,5-diol (2), along with seven known compounds (3-9) including five benzaldehyde compounds, flavoglaucin (3), tetrahydroauroglaucin (4), dihydroauroglaucin (5), auroglaucin (6), and 2-(2',3-epoxy-1',3'- heptadienyl)-6-hydroxy-5-(3-methyl-2-butenyl)benzaldehyde (7), one diketopiperazine alkaloid, echinulin (8), and 5,7-dihydroxy-4-methylphthalide (9). The chemical structures of these compounds were established on the basis of extensive 1D and 2D NMR and HRMS data. Compounds 1-4 and 6 showed good binding affinity for human opioid or cannabinoid receptors. These findings have important implications for psychoactive studies with this class of compounds.
- Published
- 2011
- Full Text
- View/download PDF